Carbonic anhydrase III (CA III) is an enzyme present in skeletal muscle which is released into circulation following injury. Myoglobin (Mb) is a heme protein located in skeletal, smooth, and cardiac muscle which is also released after injury. Because CA III is not present in myocardium, combining serum CA III and Mb measurements may improve the specificity of Mb as an early diagnostic marker for myocardial infarction (MI) provided that a fixed ratio of Mb and CA III is released from skeletal muscle following cell injury. We examined release of Mb and CA III for exercise subjects (n=12), trauma patients (n=18), and MI patients (n=10) following emergency department admission. A fixed ratio of Mb/CA III had medians of 3.505 (range: 1.05-6.76) and 2.890 (range: 0.97-3.97) for exercise and trauma subjects, respectively, in samples collected within 5 h of the event. The Mb/CA III ratio was significantly higher (P<0.001) in MI patients (median: 35.395; range: 8.65-170.45) during this same time. This study confirmed that Mb and CA III are released in a fixed ratio following exercise, showed no significant difference in the ratio for trauma patients, and demonstrated significant ratio elevation for MI patients. These data suggest the ratio to be a useful diagnostic indicator of MI.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0009-8981(99)00261-2 | DOI Listing |
Arch Pharm (Weinheim)
January 2025
Section of Pharmaceutical and Nutraceutical Sciences, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Sesto Fiorentino, Firenze, Italy.
2,2'-Thio-bis(4,6-dichlorophenol), namely bithionol, is a small molecule endowed with a multifaceted bioactivity. Its peculiar polychlorinated phenolic structure makes it a suitable candidate to explore its potentialities in establishing interaction patterns with enzymes of MedChem interest, such as the human carbonic anhydrase (hCA) metalloenzymes. Herein, bithionol was tested on a panel of specific hCAs through the stopped-flow technique, showing a promising micromolar inhibitory activity for the hCA II isoform.
View Article and Find Full Text PDFExp Cell Res
January 2025
NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, The Fourth Hospital of Harbin Medical University, Harbin, 150001, China; Department of Infectious Disease, The Fourth Hospital of Harbin Medical University, Harbin, China. Electronic address:
Lactylation is an emerging pathogenesis of hepatocellular carcinoma (HCC). However, the underlying mechanisms and biological significance remain poorly understood. The Carbonic anhydrase III (CA3) gene, previously defined as a binding protein of SQLE and involved in the NAFLD disease, has now been identified as a novel tumor suppressor in HCC.
View Article and Find Full Text PDFWiad Lek
December 2024
DEPARTMENT OF PHARMACEUTICAL CHEMISTRY, COLLEGE OF PHARMACY, UNIVERSITY OF KUFA, NAJAF, IRAQ.
Objective: Aim: To evaluate compound I, II, III, and IV's anticancer properties that have just been produced. These substances were created with the specific purpose of targeting solid tumors' carbonic anhydrase enzyme.
Patients And Methods: Materials and Methods: The chemical synthesis involved the use of 4-aminobenzenesulfonamide, Ethyl 4-aminobenzoate, isatin and its derivatives, absolute ethanol, DMF, glacial acetic acid.
Curr Issues Mol Biol
November 2024
Department of Veterinary Medicine, Susurluk Agriculture and Forestry Vocational School, Bandırma Onyedi Eylül University, Susurluk 10600, Balıkesir, Türkiye.
Colorectal cancer (CRC) is the second leading cause of cancer-related death in the world. Dysregulations in the EGF signaling pathway have been associated with colon cancer. Some members of the carbonic anhydrase family serve as biomarkers in cancer.
View Article and Find Full Text PDFACS Chem Neurosci
January 2025
Department of Pharmacy, University of Pisa, Via Bonanno, 6, 56126 Pisa, Italy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!